Cryoablation is an innovative prostate cancer treatment in which tumors are destroyed through exposure to extreme cold. Also known as cryosurgery, it can sometimes be used in place of more invasive procedures, such as a radical prostatectomy.
To perform cryoablation on a prostate tumor, a surgeon will fill a small probe with freezing gas, such as liquid nitrogen or argon. A ball of ice crystals will form around the tip of the probe. Then, using an ultrasound to guide the placement, the surgeon will bring the probe into contact with the prostate tumor to destroy the cells. The frozen tissues will eventually thaw, at which point they will be absorbed by the body.
Cryoablation is most commonly recommended for prostate cancer patients who have:
- A low prostate specific antigen (PSA) level
- A Gleason score lower than six
- A less advanced clinical stage of cancer
At Moffitt Cancer Center, we assess each patient on an individual basis to determine which treatments offer the best chances of success. If cryoablation is recommended for a prostate cancer patient, the procedure will be performed by one of our experienced surgeons, and the patient’s recovery will be monitored by a multispecialty team of medical professionals.
For cryoablation to be successful, it needs to be performed by a knowledgeable practitioner – and nobody understands that better than Moffitt. Because we treat thousands of prostate cancer surgery patients each year, our surgeons have an unmatched level of experience that allows them to provide this therapy with great accuracy and skill. At the end of the day, numbers matter, and our high-volume cancer center produces exceptional patient outcomes for cryoablation and other minimally invasive surgeries.